BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3389761)

  • 1. An antineuronal autoantibody in paraneoplastic opsoclonus.
    Budde-Steffen C; Anderson NE; Rosenblum MK; Graus F; Ford D; Synek BJ; Wray SH; Posner JB
    Ann Neurol; 1988 May; 23(5):528-31. PubMed ID: 3389761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.
    Luque FA; Furneaux HM; Ferziger R; Rosenblum MK; Wray SH; Schold SC; Glantz MJ; Jaeckle KA; Biran H; Lesser M
    Ann Neurol; 1991 Mar; 29(3):241-51. PubMed ID: 2042940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
    Anderson NE; Rosenblum MK; Posner JB
    Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antineuronal autoantibody to a 40-kDa protein in a patient with cerebellar ataxia and breast cancer].
    Kaneko A; Nishikiori E; Imai A; Hosokawa T; Hamaguchi K
    Rinsho Shinkeigaku; 1995 Mar; 35(3):277-81. PubMed ID: 7614751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
    Brieva-Ruíz L; Diaz-Hurtado M; Matias-Guiu X; Márquez-Medina D; Tarragona J; Graus F
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1044-6. PubMed ID: 18701208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.
    Pittock SJ; Lucchinetti CF; Lennon VA
    Ann Neurol; 2003 May; 53(5):580-7. PubMed ID: 12730991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer.
    Escudero D; Barnadas A; Codina M; Fueyo J; Graus F
    Neurology; 1993 Aug; 43(8):1605-6. PubMed ID: 8351021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.
    Greenlee JE; Brashear HR; Jaeckle KA; Geleris A; Jordan K
    West J Med; 1992 Feb; 156(2):199-202. PubMed ID: 1536083
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-Ri-associated paraneoplastic cerebellar and brainstem degenerative syndrome.
    Tay JK; Miller J; Joshi A; Athey RJ
    J R Coll Physicians Edinb; 2012; 42(3):221-4. PubMed ID: 22953316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic opsoclonus: a neuropathologic study of two cases.
    Giordana MT; Soffietti R; Schiffer D
    Clin Neuropathol; 1989; 8(6):295-300. PubMed ID: 2559825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmoplegia associated with the anti-Ri antibody.
    Ohmer R; Golnik KC; Richards AI; Kosmorsky GS
    J Neuroophthalmol; 1999 Dec; 19(4):246-8. PubMed ID: 10608678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated retinopathy in patients with breast carcinoma.
    Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reversible paraneoplastic cerebellar symptoms. An example of anti-Ri syndrome].
    Pfeiffer G; Grupp C
    Nervenarzt; 1998 Jun; 69(6):516-8. PubMed ID: 9673976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsoclonus: clinical and immunological features.
    Jen JC; Lopez I; Baloh RW
    J Neurol Sci; 2012 Sep; 320(1-2):61-5. PubMed ID: 22818114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.
    Antunes NL; Khakoo Y; Matthay KK; Seeger RC; Stram DO; Gerstner E; Abrey LE; Dalmau J
    J Pediatr Hematol Oncol; 2000; 22(4):315-20. PubMed ID: 10959901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptophysin is an autoantigen in paraneoplastic neuropathy.
    Tschernatsch M; Klotz M; Probst C; Hosch J; Valtorta F; Diener M; Gerriets T; Kaps M; Schäfer KH; Blaes F
    J Neuroimmunol; 2008 Jun; 197(1):81-6. PubMed ID: 18479754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.